1. Prostate cancer is the most common non-skin cancer in America, and the 4th most
common tumor diagnosed worldwide.

2. In the United States, 1 in 8 men will be diagnosed with prostate cancer in his lifetime.
For men of African descent, 1 in 5 men will develop the disease.

3. A man of African descent is 73% more likely to develop prostate cancer than a
Caucasian man, and is nearly 2.3 times more likely to die from the disease.

4. In 2017, more than 161,000 men will be diagnosed with prostate cancer, and nearly
27,000 men will die from the disease. One new case occurs every 3.3 minutes and
a man dies from prostate cancer every 20 minutes.

5. A non-smoking man is more likely to develop prostate cancer than he is to develop
colon, bladder, melanoma, lymphoma and kidney cancers combined.

6. It is estimated that more than 3 million American men are living with prostate cancer.

7. As men increase in age, their risk of developing prostate cancer increases
exponentially. About 6 in 10 cases are found in men over the age of 65.

8. Men with relatives—father, brother, son—with a history of prostate cancer are twice
as likely to develop the disease.

9. If the cancer is caught at its earliest stages, most men will not experience
any symptoms.

10. Prostate cancer is 100% treatable if detected early.

Prostate cancer is the most common non-skin cancer in America, affecting 1 in 8 men.

In 2017, more than 161,000 men will be diagnosed with prostate cancer, and nearly 27,000 men will die from the disease. One new case occurs every 3.3 minutes and
a man dies from prostate cancer every 20 minutes.

It is estimated that more than 3 million American men are living with prostate cancer.

A non-smoking man is more likely to develop prostate cancer than he is to develop colon, bladder, melanoma, lymphoma and kidney cancers combined.

As men increase in age, their risk of developing prostate cancer increases exponentially. Although only 1 in 10,000 under age 40 will be diagnosed, the rate shoots up to 1 in 38 for ages 40 to 59, and 1 in 14 for ages 60 to 69. About 60% of all prostate cancers are diagnosed in men over the age of 65 and 97% occur in men 50 years of age and older.

African American men are 56% more likely to develop prostate cancer compared with Caucasian men and nearly 2.5 times as likely to die from the disease. You can read more about prostate cancer in African American men here.

Men with a single first-degree relative—father, brother or son—with a history of prostate cancer are twice as likely to develop the disease, while those with two or more relatives are nearly four times as likely to be diagnosed. The risk is highest in men whose family members were diagnosed before age 65.

As with all cancers, “cure” rates for prostate cancer describe the percentage of patients likely remaining disease-free for a specific time. In general, the earlier the cancer is caught, the more likely it is for the patient to remain disease-free.

Because approximately 90% of all prostate cancers are detected in the local and regional stages, the cure rate for prostate cancer is very high—nearly 100% of men diagnosed at this stage will be disease-free after five years. By contrast, in the 1970s, only 67% of men diagnosed with local or regional prostate cancer were disease-free after five years.

If the cancer is caught at its earliest stages, most men will not experience any symptoms. Some men, however, will experience symptoms such as frequent, hesitant, or burning urination, difficulty in having an erection, or pain or stiffness in the lower back, hips or upper thighs.

Because these symptoms can also indicate the presence of other diseases or disorders, men who experience any of these symptoms will undergo a thorough work-up to determine the underlying cause of the symptoms. You can read more about prostate cancer symptoms here.

Screening for prostate cancer can be performed in a physician’s office using two tests: the PSA (prostate-specific antigen) blood test and the digital rectal exam (DRE).

There are a wide variety of treatment options available for men with prostate cancer, including surgery, radiation therapy, hormone therapy and chemotherapy, any or all of which might be used at different times depending on the stage of disease and the need for treatment.

Consultation with all three types of prostate cancer specialists—a urologist, a radiation oncologist and a medical oncologist—will offer the most comprehensive assessment of the available treatments and expected outcomes. More information regarding treatments for prostate cancer can be found on our website here.

Additional information about prostate cancer can be found through our Understanding Prostate Cancer section, our guides and the Treatment Options section of our website. You can order a paper copy or download our guides in pdf format here.

The Prostate Cancer Foundation (PCF) is the world’s largest philanthropic source of support for prostate cancer research to discover better treatments and a cure for prostate cancer. PCF pursues its mission by reaching out to individuals, corporations and others to harness society’s resources—financial and human—to fight this deadly disease. Founded in 1993, PCF has generated more than $615 million and provided funding for more than 2,000 research projects at nearly 200 institutions worldwide. PCF has been a pioneer in the grant making process, simplifying paperwork for grantees, leaving more time for scientific investigators to conduct needed research. PCF also advocates for greater awareness of prostate cancer and more government resources, resulting in a twenty-fold increase in government funding for prostate cancer.

The Prostate Cancer Foundation has accomplished a great deal, but there is still much more to do. Please join us in this race to find a cure for prostate cancer and donate today.

Learn More

  • Infection and Prostate Cancer

    Bacteria, Infection, Inflammation… Cancer? Guess what? Urine’s not sterile! This may be bad news for people like TV survival expert Bear Grylls, who often resorts.

    • Empowering Researchers

      PCF is unique in its innovative approach to medical research funding. PCF identifies the most promising research ideas and attracts brilliant individuals and teams.